The store will not work correctly when cookies are disabled.
9-(6-Bromo-1H-indol-3-yl)-3,4,6,7-tetrahydroacridine-1,8-(2H,5H,9H,10H)-dione
ID: ALA3121557
PubChem CID: 76336193
Max Phase: Preclinical
Molecular Formula: C21H19BrN2O2
Molecular Weight: 411.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCCC2=C1C(c1c[nH]c3cc(Br)ccc13)C1=C(CCCC1=O)N2
Standard InChI: InChI=1S/C21H19BrN2O2/c22-11-7-8-12-13(10-23-16(12)9-11)19-20-14(3-1-5-17(20)25)24-15-4-2-6-18(26)21(15)19/h7-10,19,23-24H,1-6H2
Standard InChI Key: YFJHXBINOQRNCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
2.4209 -23.9089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7006 -23.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9775 -25.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4209 -24.7339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1329 -25.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1329 -23.4922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8450 -23.9089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8415 -24.7339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5503 -25.1471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5572 -23.4972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2706 -23.9149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2668 -24.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9852 -23.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9878 -22.6772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1329 -22.6672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5596 -22.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2295 -22.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9805 -21.4077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6997 -24.7483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8948 -22.1892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1512 -21.4074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6030 -20.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7983 -20.9662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5446 -21.7521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0946 -22.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2461 -20.3531 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 4 1 0
1 6 1 0
4 5 1 0
5 8 1 0
7 6 1 0
7 8 2 0
7 10 1 0
8 9 1 0
9 12 1 0
11 10 1 0
11 12 2 0
11 13 1 0
12 3 1 0
3 19 1 0
2 13 1 0
13 14 2 0
6 15 2 0
10 16 1 0
16 17 2 0
17 18 1 0
20 16 1 0
21 18 1 0
19 2 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 411.30 | Molecular Weight (Monoisotopic): 410.0630 | AlogP: 4.63 | #Rotatable Bonds: 1 |
Polar Surface Area: 61.96 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.27 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -0.41 |
References
1. Gündüz MG, Işli F, El-Khouly A, Yıldırım S, Öztürk Fincan GS, Şimşek R, Şafak C, Sarıoğlu Y, Öztürk Yıldırım S, Butcher RJ.. (2014) Microwave-assisted synthesis and myorelaxant activity of 9-indolyl-1,8-acridinedione derivatives., 75 [PMID:24534541] [10.1016/j.ejmech.2014.01.059] |